Efficacy and Safety Study of MDV9300 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Clinical trial NCT02653989 · WITHDRAWN

Trial details

NCT number: NCT02653989
Sponsor: Medivation, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Large B-Cell, Diffuse Primary Mediastinal Large B-cell Lymphoma Transformed Indolent Lymphoma

Start date: 2016-12-01
Primary completion: 2018-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.